Accordingly, targeting ER stress/IRE1α has been proposed as a direction for the improvement of insulin resistance in obesity and diabetes (Hetz, Chevet et al. 2013, Marciniak, Chambers et al. 2021). The gene discussed is ERN1; the disease is obesity disorder.